These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11409816)

  • 1. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV.
    Zarkin GA; Lindrooth RC; Demiralp B; Wechsberg W
    Health Serv Res; 2001 Jun; 36(2):335-55. PubMed ID: 11409816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.
    Broadhead RS; Heckathorn DD; Weakliem DL; Anthony DL; Madray H; Mills RJ; Hughes J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):42-57. PubMed ID: 9722809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers.
    Cottler LB; Compton WM; Ben Abdallah A; Cunningham-Williams R; Abram F; Fichtenbaum C; Dotson W
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):31-41. PubMed ID: 9722808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of HIV counseling and testing in US prisons.
    Varghese B; Peterman TA
    J Urban Health; 2001 Jun; 78(2):304-12. PubMed ID: 11419583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
    Holtgrave DR
    PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.
    Schackman BR; Metsch LR; Colfax GN; Leff JA; Wong A; Scott CA; Feaster DJ; Gooden L; Matheson T; Haynes LF; Paltiel AD; Walensky RP
    Drug Alcohol Depend; 2013 Feb; 128(1-2):90-7. PubMed ID: 22971593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and cost-effectiveness of a church-based intervention to promote mammography screening.
    Stockdale SE; Keeler E; Duan N; Derose KP; Fox SA
    Health Serv Res; 2000 Dec; 35(5 Pt 1):1037-57. PubMed ID: 11130802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's drug use and HIV risk: findings from NIDA's Cooperative Agreement for Community-Based Outreach/Intervention Research Program.
    Coyle SL
    Women Health; 1998; 27(1-2):1-18. PubMed ID: 9640631
    [No Abstract]   [Full Text] [Related]  

  • 15. Costs and effectiveness of substance abuse treatments for homeless persons.
    Schumacher JE; Mennemeyer ST; Milby JB; Wallace D; Nolan K
    J Ment Health Policy Econ; 2002 Mar; 5(1):33-42. PubMed ID: 12529568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
    Coyle SL; Needle RH; Normand J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):19-30. PubMed ID: 9722807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of HIV infection in drug abusers: a cost analysis.
    Gorsky RD; MacGowan RJ; Swanson NM; DelGado BP
    Prev Med; 1995 Jan; 24(1):3-8. PubMed ID: 7740013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs and effectiveness of four HIV counseling and testing strategies in Uganda.
    Menzies N; Abang B; Wanyenze R; Nuwaha F; Mugisha B; Coutinho A; Bunnell R; Mermin J; Blandford JM
    AIDS; 2009 Jan; 23(3):395-401. PubMed ID: 19114865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and effectiveness issues in the NIDA Cooperative Agreement: interventions for out-of-treatment drug users. National Institute on Drug Abuse.
    Rhodes F; Wood MM; Booth RE
    J Psychoactive Drugs; 1998; 30(3):261-8. PubMed ID: 9798792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.